Page 202 - เภสัชภัณฑ์ทางผิวหนัง-14052022
P. 202
transdermal drug delivery system. International Journal of Pharma Professional’s
Research 2, 212–219.
British Pharmacopoeia, 2015. British Pharmacopoeia Commission Office, London.
th
Council of Europe (Ed.), 2019. European Pharmacopoeia, 10 ed.
Devarakonda, B., Otto, D.P., Judefeind, A., Hill, R.A., de Villiers, M.M., 2007. Effect of pH
on the solubility and release of furosemide from polyamidoamine (PAMAM)
dendrimer complexes. International Journal of Pharmaceutics 345, 142–153.
https://doi.org/https://doi.org/10.1016/j.ijpharm.2007.05.039
Dykes, P.J., Pearse, A.D., 2002. Safety considerations for dermal and transdermal
formulations, in: Walters, K. (Ed.), Dermatological and transdermal formulations.
Marcel Dekker Inc., New York.
Gaikwad, A., 2013. Transdermal drug delivery system: formulation aspects and
evaluation. Comprehensive Journal of Pharmaceutical Sciences 1, 1–10.
Godin, B., Touitou, E., 2007. Transdermal skin delivery: Predictions for humans from in
vivo, ex vivo and animal models. Advanced Drug Delivery Reviews 59, 1152–1161.
https://doi.org/https://doi.org/10.1016/j.addr.2007.07.004
Kaewsrinon, N., Changnak, P., Phunanue, T., Rattanakiat, S., Mekjaruskul, C., 2017.
Development of cleaning toner from Puag-Haad. Isan Journal of Pharmaceutical
Sciences2 13 Supple, 1–9.
Khar, R., Vyas, S., Ahmad, F., Jain, G., 2013. The Theory and practice of industrial
pharmacy, 4 ed. CBS Publishers and Distributors Pvt. Ltd., India.
th
Kim, B., Cho, H.-E., Moon, S.H., Ahn, H.-J., Bae, S., Cho, H.-D., An, S., 2020. Transdermal
delivery systems in cosmetics. Biomedical Dermatology 4, 10.
https://doi.org/10.1186/s41702-020-0058-7
Kim, Y.-H., Heinze, T.M., Beger, R., Pothuluri, J. V, Cerniglia, C.E., 2004. A kinetic study on
the degradation of erythromycin A in aqueous solution. International Journal of
Pharmaceutics 271, 63–76.
https://doi.org/https://doi.org/10.1016/j.ijpharm.2003.10.023
Li, V.C.Y., Chowdhury, M.M.U., 2017. Dermatological pharmacology: topical agents.
188
